New York State Common Retirement Fund’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Buy
24,617
+9,162
+59% +$589K ﹤0.01% 1497
2026
Q1
$871K Hold
15,455
﹤0.01% 1703
2025
Q4
$1.24M Sell
15,455
-1,500
-9% -$101K ﹤0.01% 1621
2025
Q3
$826K Hold
16,955
﹤0.01% 1753
2025
Q2
$1.27M Buy
16,955
+1,400
+9% +$92.7K ﹤0.01% 1584
2025
Q1
$989K Hold
15,555
﹤0.01% 1631
2024
Q4
$1.21M Hold
15,555
﹤0.01% 1607
2024
Q3
$1.25M Sell
15,555
-18,900
-55% -$1.53M ﹤0.01% 1577
2024
Q2
$2.85M Buy
34,455
+3,767
+12% +$331K ﹤0.01% 1334
2024
Q1
$2.62M Sell
30,688
-14
-0% -$1.1K ﹤0.01% 1364
2023
Q4
$2.63M Sell
30,702
-30,071
-49% -$2.6M ﹤0.01% 1353
2023
Q3
$5.44M Buy
60,773
+25,052
+70% +$2.24M 0.01% 1074
2023
Q2
$3.04M Sell
35,721
-26,652
-43% -$2.25M ﹤0.01% 1354
2023
Q1
$5.16M Buy
62,373
+10,880
+21% +$881K 0.01% 1152
2022
Q4
$4.05M Buy
51,493
+1,274
+3% +$102K 0.01% 1274
2022
Q3
$3.72M Buy
50,219
+202
+0.4% +$14.5K 0.01% 1303
2022
Q2
$3.26M Buy
50,017
+1,608
+3% +$95.2K ﹤0.01% 1400
2022
Q1
$3.06M Buy
48,409
+38
+0.1% +$2.07K ﹤0.01% 1532
2021
Q4
$2.57M Buy
48,371
+1,747
+4% +$106K ﹤0.01% 1646
2021
Q3
$3.29M Sell
46,624
-16,609
-26% -$1.05M ﹤0.01% 1487
2021
Q2
$4.21M Sell
63,233
-5,831
-8% -$413K ﹤0.01% 1418
2021
Q1
$7.67M Sell
69,064
-7,000
-9% -$866K 0.01% 1087
2020
Q4
$9.03M Sell
76,064
-7,200
-9% -$775K 0.01% 1007
2020
Q3
$7.26M Sell
83,264
-504
-0.6% -$44K 0.01% 1009
2020
Q2
$7.5M Buy
83,768
+30,200
+56% +$3.05M 0.01% 991
2020
Q1
$5.34M Buy
53,568
+7,568
+16% +$821K 0.01% 1033
2019
Q4
$5.29M Sell
46,000
-16,075
-26% -$1.95M 0.01% 1226
2019
Q3
$7.83M Buy
62,075
+9,575
+18% +$1.22M 0.01% 1043
2019
Q2
$6.32M Sell
52,500
-700
-1% -$68.9K 0.01% 1174
2019
Q1
$4.65M Sell
53,200
-7,755
-13% -$705K 0.01% 1270
2018
Q4
$6.1M Sell
60,955
-4,125
-6% -$433K 0.01% 1098
2018
Q3
$7.46M Sell
65,080
-2,820
-4% -$292K 0.01% 1118
2018
Q2
$6.09M Sell
67,900
-34,347
-34% -$2.9M 0.01% 1193
2018
Q1
$7.48M Hold
102,247
0.01% 1083
2017
Q4
$5.94M Buy
102,247
+44,347
+77% +$2.34M 0.01% 1182
2017
Q3
$2.6M Hold
57,900
﹤0.01% 1498
2017
Q2
$2.29M Sell
57,900
-1,728
-3% -$71K ﹤0.01% 1597
2017
Q1
$2.42M Buy
59,628
+359
+0.6% +$14K ﹤0.01% 1553
2016
Q4
$2.38M Buy
59,269
+1,500
+3% +$56.6K ﹤0.01% 1597
2016
Q3
$2.09M Hold
57,769
﹤0.01% 1627
2016
Q2
$1.68M Hold
57,769
﹤0.01% 1698
2016
Q1
$2.02M Buy
57,769
+2,000
+4% +$64.6K ﹤0.01% 1579
2015
Q4
$1.8M Buy
55,769
+1,600
+3% +$51.9K ﹤0.01% 1651
2015
Q3
$1.75M Sell
54,169
-93,007
-63% -$3.5M ﹤0.01% 1657
2015
Q2
$6.09M Buy
147,176
+44,236
+43% +$1.86M 0.01% 1238
2015
Q1
$4.62M Hold
102,940
0.01% 1253
2014
Q4
$3.85M Buy
102,940
+1,400
+1% +$51.3K 0.01% 1333
2014
Q3
$3.55M Sell
101,540
-22,000
-18% -$785K 0.01% 1359
2014
Q2
$4.36M Buy
123,540
+2,500
+2% +$83.5K 0.01% 1326
2014
Q1
$3.94M Hold
121,040
0.01% 1339
2013
Q4
$5.1M Hold
121,040
0.01% 1215
2013
Q3
$4.83M Sell
121,040
-1,500
-1% -$62.9K 0.01% 1189
2013
Q2
$5.07M Buy
+122,540
New +$4.96M 0.01% 1086

Other funds holding HAE

New York State Common Retirement Fund's HAE Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Haemonetics (HAE) stake by 59% in Q2 2026, buying an estimated $589K and bringing the position to 24,617 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

New York State Common Retirement Fund first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.03M in Q4 2020. 108 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • New York State Common Retirement Fund held 24,617 shares of Haemonetics worth $1.85M as of Q2 2026.
  • New York State Common Retirement Fund bought 9,162 Haemonetics shares in Q2 2026, an estimated $589K.
  • Haemonetics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1497 holding.
  • New York State Common Retirement Fund first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • New York State Common Retirement Fund's Haemonetics position peaked at $9.03M in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.